Renaissance Technologies - RENEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$274
-31.7%
36,000
-41.1%
0.00%
-100.0%
Q2 2023$401
+162.1%
61,114
+138.7%
0.00%
Q1 2023$153
+75.9%
25,600
-31.2%
0.00%
Q4 2022$87
-99.9%
37,200
-13.5%
0.00%
Q3 2022$144,000
+136.1%
43,000
+87.0%
0.00%
Q2 2022$61,00023,0000.00%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$6,384,0009.38%
Abingworth LLP 2,073,957$5,413,0001.73%
Aisling Capital Management LP 886,075$2,348,0001.68%
NEA Management Company, LLC 4,786,921$12,685,0000.65%
Novo Holdings A/S 3,430,377$9,090,0000.45%
Ikarian Capital, LLC 185,597$491,0000.09%
Rock Springs Capital Management LP 1,143,185$3,029,0000.09%
Newtyn Management, LLC 20,983$56,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$186,0000.00%
Ergoteles LLC 42,400$112,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders